200 related articles for article (PubMed ID: 29417765)
1. Conflicting evidence for the role of JNK as a target in breast cancer cell proliferation: Comparisons between pharmacological inhibition and selective shRNA knockdown approaches.
Wood RA; Barbour MJ; Gould GW; Cunningham MR; Plevin RJ
Pharmacol Res Perspect; 2018 Feb; 6(1):. PubMed ID: 29417765
[TBL] [Abstract][Full Text] [Related]
2. C-Jun N-terminal kinase (JNK) regulation of iNOS expression in glial cells: predominant role of JNK1 isoform.
Pawate S; Bhat NR
Antioxid Redox Signal; 2006; 8(5-6):903-9. PubMed ID: 16771680
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cell proliferation and cell cycle progression by specific inhibition of basal JNK activity: evidence that mitotic Bcl-2 phosphorylation is JNK-independent.
Du L; Lyle CS; Obey TB; Gaarde WA; Muir JA; Bennett BL; Chambers TC
J Biol Chem; 2004 Mar; 279(12):11957-66. PubMed ID: 14704147
[TBL] [Abstract][Full Text] [Related]
4. [Impact of PTEN gene knockout in human breast carcinoma MCF-7 cells on activity of JNK pathway].
Jin Y; Hu JL; Xiao L; Cui W
Ai Zheng; 2008 Dec; 27(12):1239-43. PubMed ID: 19079986
[TBL] [Abstract][Full Text] [Related]
5. Role of mitogen-activated protein kinases and Mcl-1 in apoptosis induction by withaferin A in human breast cancer cells.
Hahm ER; Lee J; Singh SV
Mol Carcinog; 2014 Nov; 53(11):907-16. PubMed ID: 24019090
[TBL] [Abstract][Full Text] [Related]
6. IGF-I plus E2 induces proliferation via activation of ROS-dependent ERKs and JNKs in human breast carcinoma cells.
Lin CW; Yang LY; Shen SC; Chen YC
J Cell Physiol; 2007 Sep; 212(3):666-74. PubMed ID: 17458902
[TBL] [Abstract][Full Text] [Related]
7. Role of c-Jun N-terminal kinase isoforms in the cellular activity of melanoma cell lines.
Kogushi-Nishi H; Jinnin M; Kobayashi Y; Muchemwa FC; Hirano A; Makino T; Fukushima S; Masuguchi S; Ishihara T; Inoue Y; Ihn H
Clin Exp Dermatol; 2013 Dec; 38(8):890-6. PubMed ID: 24252081
[TBL] [Abstract][Full Text] [Related]
8. JNK supports survival in melanoma cells by controlling cell cycle arrest and apoptosis.
Alexaki VI; Javelaud D; Mauviel A
Pigment Cell Melanoma Res; 2008 Aug; 21(4):429-38. PubMed ID: 18541008
[TBL] [Abstract][Full Text] [Related]
9. BEX2 promotes tumor proliferation in colorectal cancer.
Hu Y; Xiao Q; Chen H; He J; Tan Y; Liu Y; Wang Z; Yang Q; Shen X; Huang Y; Yuan Y; Ding K
Int J Biol Sci; 2017; 13(3):286-294. PubMed ID: 28367093
[TBL] [Abstract][Full Text] [Related]
10. Gene silencing of FANCF potentiates the sensitivity to mitoxantrone through activation of JNK and p38 signal pathways in breast cancer cells.
Li Y; Zhao L; Sun H; Yu J; Li N; Liang J; Wang Y; He M; Bai X; Yu Z; Zheng Z; Mi X; Wang E; Wei M
PLoS One; 2012; 7(8):e44254. PubMed ID: 22952942
[TBL] [Abstract][Full Text] [Related]
11. ROCK1 knockdown inhibits non-small-cell lung cancer progression by activating the LATS2-JNK signaling pathway.
Xin T; Lv W; Liu D; Jing Y; Hu F
Aging (Albany NY); 2020 Jun; 12(12):12160-12174. PubMed ID: 32554853
[TBL] [Abstract][Full Text] [Related]
12. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
Tyagi A; Agarwal R; Agarwal C
Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
[TBL] [Abstract][Full Text] [Related]
13. Identification of the ZAK-MKK4-JNK-TGFβ signaling pathway as a molecular target for novel synthetic iminoquinone anticancer compound BA-TPQ.
Chen D; Wang W; Qin JJ; Wang MH; Murugesan S; Nadkarni DH; Velu SE; Wang H; Zhang R
Curr Cancer Drug Targets; 2013 Jul; 13(6):651-60. PubMed ID: 23607596
[TBL] [Abstract][Full Text] [Related]
14. c-Jun N-terminal kinase activity supports multiple phases of 3D-mammary epithelial acinus formation.
McNally S; McArdle E; Gilligan E; Napoletano S; Gajewska M; Bergin O; McCarthy S; Whyte J; Bianchi A; Stack J; Martin F
Int J Dev Biol; 2011; 55(7-9):731-44. PubMed ID: 22161830
[TBL] [Abstract][Full Text] [Related]
15. The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cells.
Li DD; Wang LL; Deng R; Tang J; Shen Y; Guo JF; Wang Y; Xia LP; Feng GK; Liu QQ; Huang WL; Zeng YX; Zhu XF
Oncogene; 2009 Feb; 28(6):886-98. PubMed ID: 19060920
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of JNK reduces G2/M transit independent of p53, leading to endoreduplication, decreased proliferation, and apoptosis in breast cancer cells.
Mingo-Sion AM; Marietta PM; Koller E; Wolf DM; Van Den Berg CL
Oncogene; 2004 Jan; 23(2):596-604. PubMed ID: 14724588
[TBL] [Abstract][Full Text] [Related]
17. SP600125 induces Src and type I IGF receptor phosphorylation independent of JNK.
Kong Q; Hua H; Cui A; Shao T; Song P; Jiang Y
Int J Mol Sci; 2014 Sep; 15(9):16246-56. PubMed ID: 25226534
[TBL] [Abstract][Full Text] [Related]
18. JNK pathway signaling: a novel and smarter therapeutic targets for various biological diseases.
Kumar A; Singh UK; Kini SG; Garg V; Agrawal S; Tomar PK; Pathak P; Chaudhary A; Gupta P; Malik A
Future Med Chem; 2015; 7(15):2065-86. PubMed ID: 26505831
[TBL] [Abstract][Full Text] [Related]
19. The TAK1-JNK cascade is required for IRF3 function in the innate immune response.
Zhang B; Li M; Chen L; Yang K; Shan Y; Zhu L; Sun S; Li L; Wang C
Cell Res; 2009 Apr; 19(4):412-28. PubMed ID: 19153595
[TBL] [Abstract][Full Text] [Related]
20. Basal c-Jun NH2-terminal protein kinase activity is essential for survival and proliferation of T-cell acute lymphoblastic leukemia cells.
Cui J; Wang Q; Wang J; Lv M; Zhu N; Li Y; Feng J; Shen B; Zhang J
Mol Cancer Ther; 2009 Dec; 8(12):3214-22. PubMed ID: 19996270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
